- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting B Cells and Plasma Cells in Autoimmune Diseases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-23
DOI
10.3389/fimmu.2018.00835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B cells and their cytokine activities implications in human diseases
- (2018) Simon Fillatreau CLINICAL IMMUNOLOGY
- Belimumab: A Review in Systemic Lupus Erythematosus
- (2018) Hannah A. Blair et al. DRUGS
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- The discovery of plasma cells: An historical note
- (2017) Domenico Ribatti IMMUNOLOGY LETTERS
- Human regulatory B cells in health and disease: therapeutic potential
- (2017) Claudia Mauri et al. JOURNAL OF CLINICAL INVESTIGATION
- Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy
- (2017) Qiming Wang et al. JOURNAL OF IMMUNOLOGY
- Induction and Differentiation of IL-10–Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients
- (2017) Zsuzsanna Bankó et al. JOURNAL OF IMMUNOLOGY
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Antinuclear antibody testing — misunderstood or misbegotten?
- (2017) David S. Pisetsky Nature Reviews Rheumatology
- Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
- (2017) Michaela Seeling et al. Nature Reviews Rheumatology
- Memory B cell resurgence requires repeated rituximab in myasthenia gravis
- (2017) Kohei Muto et al. NEUROMUSCULAR DISORDERS
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial
- (2017) Seerapani Gopaluni et al. Trials
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- Current perspective on rituximab in rheumatic diseases
- (2017) Tommaso Schioppo et al. Drug Design Development and Therapy
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
- (2017) Eleonore Fröhlich et al. Frontiers in Immunology
- Chronic Exposure to Malaria Is Associated with Inhibitory and Activation Markers on Atypical Memory B Cells and Marginal Zone-Like B Cells
- (2017) Itziar Ubillos et al. Frontiers in Immunology
- Mechanisms of Autoantibody-Induced Pathology
- (2017) Ralf J. Ludwig et al. Frontiers in Immunology
- Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
- (2017) Michael J. E. Marshall et al. Frontiers in Immunology
- Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus
- (2016) Qian Zhao et al. CLINICAL DRUG INVESTIGATION
- A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins
- (2016) A.S. Rosenberg et al. CLINICAL IMMUNOLOGY
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus
- (2016) Madhvi Menon et al. IMMUNITY
- Control of memory B cell responses by extrinsic and intrinsic mechanisms
- (2016) Jürgen Wienands et al. IMMUNOLOGY LETTERS
- IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration
- (2016) Upasana Kulkarni et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Germinal center B cells recognize antigen through a specialized immune synapse architecture
- (2016) Carla R Nowosad et al. NATURE IMMUNOLOGY
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Plasma cells as an innovative target in autoimmune disease with renal manifestations
- (2016) Falk Hiepe et al. Nature Reviews Nephrology
- Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells
- (2016) Sarantis Korniotis et al. Nature Communications
- Anti-CD20 monoclonal antibodies in multiple sclerosis
- (2016) Irene Moreno Torres et al. Expert Review of Neurotherapeutics
- Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice
- (2016) Nichol E. Holodick et al. Frontiers in Immunology
- Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves’ Disease: An Encrypted Message Sent by Animal Models
- (2016) Yuqian Luo et al. Frontiers in Endocrinology
- Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice
- (2015) Shang-xue Yan et al. ACTA PHARMACOLOGICA SINICA
- Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
- (2015) A. de Masson et al. BLOOD
- Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases
- (2015) Charles E. Egwuagu et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases
- (2015) Andreia C. Lino et al. IMMUNOLOGICAL REVIEWS
- Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research
- (2015) Tomomitsu Miyagaki et al. INTERNATIONAL IMMUNOLOGY
- The expanding family of regulatory B cells
- (2015) Claudia Mauri et al. INTERNATIONAL IMMUNOLOGY
- Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
- (2015) Juan Jakez-Ocampo et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Complexity of the human memory B-cell compartment is determined by the versatility of clonal diversification in germinal centers
- (2015) Bettina Budeus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions
- (2015) Marc Seifert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity
- (2015) Takashi Matsushita et al. RHEUMATOLOGY
- Plasmazellen
- (2015) F. Hiepe et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
- (2015) Adriano Taddeo et al. ARTHRITIS RESEARCH & THERAPY
- Proteasome inhibitors as experimental therapeutics of autoimmune diseases
- (2015) Sue Verbrugge et al. ARTHRITIS RESEARCH & THERAPY
- The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis
- (2015) Ceri A. Roberts et al. Frontiers in Immunology
- B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
- (2015) Nele Claes et al. Frontiers in Immunology
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
- (2014) P Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Bortezomib for Refractory Autoimmunity in Pediatrics
- (2014) Pooja Khandelwal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impaired function of CD19+CD24hiCD38hiregulatory B cells in patients with pemphigus
- (2014) H.-Q. Zhu et al. BRITISH JOURNAL OF DERMATOLOGY
- From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets
- (2014) Van Duc Dang et al. CURRENT OPINION IN IMMUNOLOGY
- Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts
- (2014) Guido Heine et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
- (2014) Masanori Matsumoto et al. IMMUNITY
- High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis
- (2014) Anaïs Gardette et al. JOINT BONE SPINE
- Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry
- (2014) F. De Keyser et al. JOURNAL OF RHEUMATOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- IgG1 protects against renal disease in a mouse model of cryoglobulinaemia
- (2014) Richard T. Strait et al. NATURE
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production
- (2014) Elizabeth C Rosser et al. NATURE MEDICINE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant
- (2014) Bhakti Mehta et al. PEDIATRIC BLOOD & CANCER
- Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
- (2014) Paul Emery et al. PLoS One
- Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report
- (2014) Sean Yates et al. TRANSFUSION
- A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell-activating factor monoclonal antibody, for rheumatoid arthritis
- (2014) Maria Greenwald et al. ARTHRITIS RESEARCH & THERAPY
- Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity
- (2014) Claire I. Daien et al. Arthritis & Rheumatology
- Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis
- (2014) Stephanie Glaesener et al. Arthritis & Rheumatology
- Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
- (2014) Jeremy Sokolove et al. Arthritis & Rheumatology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical Response
- (2013) J. Mélet et al. ARTHRITIS AND RHEUMATISM
- ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review
- (2013) Petar Lenert et al. CLINICAL RHEUMATOLOGY
- Genome-wide association studies to advance our understanding of critical cell types and pathways in rheumatoid arthritis
- (2013) Dorothée Diogo et al. CURRENT OPINION IN RHEUMATOLOGY
- Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib
- (2013) Tessa van Balen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies
- (2013) Mattias Collin et al. EXPERIMENTAL DERMATOLOGY
- The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
- (2013) G. Cambridge et al. JOURNAL OF AUTOIMMUNITY
- T cell–independent B cell activation induces immunosuppressive sialylated IgG antibodies
- (2013) Constanze Hess et al. JOURNAL OF CLINICAL INVESTIGATION
- Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells
- (2013) Elissa K. Deenick et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
- (2013) W. Stohl et al. JOURNAL OF RHEUMATOLOGY
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis
- (2013) Feng Sun et al. MUSCLE & NERVE
- Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells
- (2013) Daniela A Bermejo et al. NATURE IMMUNOLOGY
- Humoral Pattern Recognition and the Complement System
- (2013) S. E. Degn et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Maintain Regulatory T Cells While Limiting TH1 and TH17 Differentiation
- (2013) F. Flores-Borja et al. Science Translational Medicine
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
- (2013) N. Colliou et al. Science Translational Medicine
- B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
- (2013) Maria J Leandro ARTHRITIS RESEARCH & THERAPY
- Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
- (2012) Alejandro M. Gomez et al. Annals of the New York Academy of Sciences
- Immune Regulatory Function of B Cells
- (2012) Claudia Mauri et al. Annual Review of Immunology
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Tolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs
- (2012) Carolin M. Oefner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: IL-21 Derived from Human Follicular Helper T Cells Acts as a Survival Factor for Secondary Lymphoid Organ, but Not for Bone Marrow, Plasma Cells
- (2012) B. Rodriguez-Bayona et al. JOURNAL OF IMMUNOLOGY
- The Skin, a Novel Niche for Recirculating B Cells
- (2012) S. A. Geherin et al. JOURNAL OF IMMUNOLOGY
- CD19 as an attractive target for antibody-based therapy
- (2012) Ohad Hammer mAbs
- Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1
- (2012) Christian M Karsten et al. NATURE MEDICINE
- Schistosomes Induce Regulatory Features in Human and Mouse CD1dhi B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells
- (2012) Luciën E. P. M. van der Vlugt et al. PLoS One
- Innate Response Activator B Cells Protect Against Microbial Sepsis
- (2012) P. J. Rauch et al. SCIENCE
- Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
- (2012) M. Couderc et al. ARTHRITIS CARE & RESEARCH
- Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity
- (2012) YK Onno Teng et al. ARTHRITIS RESEARCH & THERAPY
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Protective Roles of Natural IgM Antibodies
- (2012) Caroline Grönwall et al. Frontiers in Immunology
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment
- (2011) Preeti Lal et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- BAFF inhibition: A new class of drugs for the treatment of autoimmunity
- (2011) Zheng Liu et al. EXPERIMENTAL CELL RESEARCH
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
- (2011) A. M. Gomez et al. JOURNAL OF IMMUNOLOGY
- Regulatory B10 Cells Differentiate into Antibody-Secreting Cells After Transient IL-10 Production In Vivo
- (2011) D. Maseda et al. JOURNAL OF IMMUNOLOGY
- Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission
- (2011) Stephanie Knippenberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and Effectiveness of Rituximab in Patients with Rheumatoid Arthritis Following an Inadequate Response to 1 Prior Tumor Necrosis Factor Inhibitor: The RESET Trial
- (2011) BOULOS HARAOUI et al. JOURNAL OF RHEUMATOLOGY
- Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies-Induced Glomerulonephritis
- (2011) J. Bontscho et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide
- (2010) Pongwut Danchaivijitr et al. AMERICAN JOURNAL OF HEMATOLOGY
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis
- (2010) Altan Ercan et al. ARTHRITIS AND RHEUMATISM
- Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?
- (2010) Maurizio Benucci et al. AUTOIMMUNITY REVIEWS
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
- (2010) Sudhanshu Agrawal et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
- (2010) Robert M. Anthony et al. JOURNAL OF CLINICAL IMMUNOLOGY
- TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica
- (2010) T. A. Barr et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- Depletion of functionally active CD20+ T cells by rituximab treatment
- (2009) Esther Wilk et al. ARTHRITIS AND RHEUMATISM
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Anti-CD20 monoclonal antibodies: historical and future perspectives
- (2009) S. H. Lim et al. HAEMATOLOGICA
- Multiple layers of B cell memory with different effector functions
- (2009) Ismail Dogan et al. NATURE IMMUNOLOGY
- Regulatory T cells as therapeutic targets in rheumatoid arthritis
- (2009) Jonathan H. Esensten et al. Nature Reviews Rheumatology
- CD19: a promising B cell target for rheumatoid arthritis
- (2009) Thomas F. Tedder Nature Reviews Rheumatology
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- (2008) D Albert et al. ANNALS OF THE RHEUMATIC DISEASES
- Peripheral B cell subsets
- (2008) David Allman et al. CURRENT OPINION IN IMMUNOLOGY
- Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab
- (2008) Martin Pfütze et al. DERMATOLOGY
- Complement and cellular cytotoxicity in antibody therapy of cancer
- (2008) Siao-Yi Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling
- (2008) Claire A. Walshe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated B cells in autoimmune diseases: the case for a regulatory role
- (2008) Stephen M Anderton et al. Nature clinical practice. Rheumatology
- Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab
- (2007) Alastair J. Ferraro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now